Xianglin Ren

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

L-3 Communications (United States)(Current)

Xianglin Ren is an author at L-3 Communications (United States) specializing in anti-inflammatory pharmacology, pharmacology, and medicinal chemistry.

Publications per year

2018–2020

Publications

Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO)

Anup Patnaik, Laura Axford, Evan Cohick et al. · Bioorganic & Medicinal Chemistry · 2020 · 16 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

Discovery of 1-((6-Aminopyridin-3-yl)Methyl)-3-(4-Bromophenyl)Urea as a Potent, Irreversible Myeloperoxidase Inhibitor

Martı́n L. Marro, Andrew W. Patterson, Lac Lee et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 13 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

1–2 of 2